EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus

Dionysis Nikolopoulos, Sofia Pitsigavdaki, Danae-Mona Nöthling, Spyridon Katechis, Myrto Nikoloudaki, Christina Bergmann, Ettore Silvagni, Argyro Repa, Andreas Ramming, Antonio Marangoni, Marcello Govoni, Prodromos Sidiropoulos und 6 weitere

Annals of the Rheumatic Diseases · 2026

DOI: 10.1016/j.ard.2026.06.013 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Dionysis Nikolopoulos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Center for Molecula…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Severity of Illness Index, Symptom Flare Up. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Crete.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Flares are key determinants of outcome in systemic lupus erythematosus (SLE), yet the conventional mild/moderate vs severe classification inadequately reflects prognosis. We sought to refine flare classification to improve damage prediction and develop a data-driven flare score. METHODS: We analysed a multicentre longitudinal cohort of 354 patients with active SLE requiring treatment at inclusion (median follow-up 66 months). Flares were adjudicated using a modified Safety of Estrogens in Lupus Erythematosus National Assessment-SLE Disease Activity Index Flare Index (SFI). Random Forests and modified flare definitions assessed the contribution of individual SFI variables to subsequent damage. We derived a flare score using bootstrap-validated mixed-effects models. This was validated in an independent cohort (n = 110). RESULTS: Both mild/moderate and severe SFI flares contributed to elevated 12-month damage risk (incidence rate ratio [IRR]:1.42 and 1.54, respectively). Among SFI subcriteria, major organ involvement requiring high-dose glucocorticoids (GCs) ranked highest for damage prediction (weight = 6), followed by the isolated GCs escalation criteria (weights = 1.5-3), whereas minor organ involvement and immunosuppressants/biologics addition carried lower weights (1 each). A flare score based on these subcriteria demonstrated good predictive performance (Brier score = 0.07). A threshold of ≥ 3.5 identified a subset of high-risk flares (40% of all episodes) that displayed the strongest association with subsequent damage (IRR: 2.49, 95% CI: 1.51-4.10) and outperformed the original SFI definition in the validation cohort (area under the curve-receiver operating characteristic: 0.893 vs 0.816). Although both Definitions of Remission in SLE (DORIS) and lupus low disease activity state correlated with lower risk of SFI-defined flares, only sustained DORIS (>50% of time) reduced high-risk flares. CONCLUSIONS: We defined and validated a novel weighted SLE flare score that better predicts damage accrual and may support treat-to-target implementation and clinical trial design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicSeverity of Illness IndexSymptom Flare UpHumansFemaleGlucocorticoidsMaleAdultImmunosuppressive AgentsPrognosisLongitudinal StudiesMiddle AgedDisease Progression

Substanzen

GlucocorticoidsImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine (CMM), Stockholm, Sweden.
  • Rheumatology and Clinical Immunology, University of Crete Medical School, Heraklion, Greece.
  • Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), FAU Erl…
  • 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy.
  • Rheumatology and Clinical Immunology, University of Crete Medical School, Heraklion, Greece; Division of Immunity, Institute of Molecular Biology and Biotechnology-Foundation for Research and Technology - Hellas (FORTH)…

Förderung

  • University of Crete

Zitieren

APA

Nikolopoulos, D., Pitsigavdaki, S., Nöthling, D. M., Katechis, S., Nikoloudaki, M., Bergmann, C., Silvagni, E., Repa, A., Ramming, A., Marangoni, A., Govoni, M., Sidiropoulos, P., Fanouriakis, A., Boumpas, D., Schett, G., Bortoluzzi, A., Garantziotis, P., & Bertsias, G. (2026). A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.06.013

Vancouver

Nikolopoulos D, Pitsigavdaki S, Nöthling DM, Katechis S, Nikoloudaki M, Bergmann C, et al. A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.06.013

BibTeX
@article{Nikolopoulos2026,
  author = {Nikolopoulos, Dionysis and Pitsigavdaki, Sofia and Nöthling, Danae-Mona and Katechis, Spyridon and Nikoloudaki, Myrto and Bergmann, Christina and Silvagni, Ettore and Repa, Argyro and Ramming, Andreas and Marangoni, Antonio and Govoni, Marcello and Sidiropoulos, Prodromos and Fanouriakis, Antonis and Boumpas, Dimitrios and Schett, Georg and Bortoluzzi, Alessandra and Garantziotis, Panagiotis and Bertsias, George},
  title = {A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2026.06.013}
}
Kostenlos starten →